{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T21:02:16Z","timestamp":1764709336843,"version":"3.46.0"},"reference-count":31,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"9","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Clin Cancer Inform"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE<\/jats:title>\n                    <jats:p>Selecting an optimal first-line chemotherapy regimen for advanced or metastatic pancreatic cancer is challenging because of varying efficacy and toxicity profiles of fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX) and gemcitabine\/nab-paclitaxel (GnP). This study aimed to develop machine learning (ML) models that predict survival outcomes and guide treatment selection using routinely available clinical data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>We retrospectively analyzed 191 patients who received systemic chemotherapy for advanced or metastatic pancreatic cancer at Gangneung Asan Hospital and the Asan Medical Center between 2014 and 2023. Seventeen demographic and clinical variables, along with survival outcomes, were collected. The data set was stratified and split into training and test sets (4:1). CatBoost-based ML models were trained to predict 12-month overall survival (OS) for each regimen. A minimal subset of variables was selected using 5-fold cross-validation to optimize receiver operating characteristic (ROC)-AUC. Patients were classified as high or low risk based on model-derived thresholds.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      The median age of the cohort was 62 years, and 64% was male. The ML models achieved ROC-AUCs of 0.81 for FOLFIRINOX and 0.82 for GnP. Predictive accuracies on test data were 0.77 and 0.80, respectively. Median OS differed significantly between predicted high- and low-risk groups: 9\n                      <jats:italic toggle=\"yes\">v<\/jats:italic>\n                      15 months for FOLFIRINOX (hazard ratio [HR], 2.8;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .0001) and 9\n                      <jats:italic toggle=\"yes\">v<\/jats:italic>\n                      18 months for GnP (HR, 2.5;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .01). In addition, 27% of patients predicted to be high risk for FOLFIRINOX were classified as low risk for GnP, and 32% vice versa.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>ML models trained on multicenter data can effectively predict early mortality risk and help personalize chemotherapy selection in advanced or metastatic pancreatic cancer, potentially improving clinical outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/cci-25-00124","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T21:00:13Z","timestamp":1764709213000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":0,"title":["Predicting Chemotherapy Response in Patients With Advanced or Metastatic Pancreatic Cancer Using Machine Learning"],"prefix":"10.1200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4299-1546","authenticated-orcid":true,"given":"Jamin","family":"Koo","sequence":"first","affiliation":[{"name":"ImpriMed Korea, Inc, Seoul, Republic of Korea"},{"name":"ImpriMed, Inc, Mountain View, CA"},{"name":"Department of Chemical Engineering, Hongik University, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gyucheol","family":"Choi","sequence":"additional","affiliation":[{"name":"ImpriMed Korea, Inc, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaekyung","family":"Cheon","sequence":"additional","affiliation":[{"name":"Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1451-8455","authenticated-orcid":true,"given":"Changhoon","family":"Yoo","sequence":"additional","affiliation":[{"name":"Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8622-6251","authenticated-orcid":true,"given":"George","family":"Courcoubetis","sequence":"additional","affiliation":[{"name":"ImpriMed, Inc, Mountain View, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9052-833X","authenticated-orcid":true,"given":"Baek-Yeol","family":"Ryoo","sequence":"additional","affiliation":[{"name":"Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyu-Pyo","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heung-Moon","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho-Suk","family":"Oh","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, University of Ulsan College of Medicine, Gangneung Asan Hospital, Gangneung, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8295-3072","authenticated-orcid":true,"given":"Sungwon","family":"Lim","sequence":"additional","affiliation":[{"name":"ImpriMed Korea, Inc, Seoul, Republic of Korea"},{"name":"ImpriMed, Inc, Mountain View, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1777-3267","authenticated-orcid":true,"given":"Moonho","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, University of Ulsan College of Medicine, Gangneung Asan Hospital, Gangneung, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","reference":[{"key":"e_1_3_7_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21820"},{"key":"e_1_3_7_3_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02616"},{"key":"e_1_3_7_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1011923"},{"key":"e_1_3_7_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1304369"},{"key":"e_1_3_7_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.13027"},{"key":"e_1_3_7_7_2","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.130362"},{"key":"e_1_3_7_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-022-01134-8"},{"key":"e_1_3_7_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djaa073"},{"key":"e_1_3_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101234"},{"key":"e_1_3_7_11_2","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2020.00196"},{"key":"e_1_3_7_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100555"},{"key":"e_1_3_7_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-023-00697-7"},{"key":"e_1_3_7_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-023-00385-w"},{"key":"e_1_3_7_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-018-0598-5"},{"key":"e_1_3_7_16_2","first-page":"2825","article-title":"Scikit-learn: Machine learning in python","volume":"12","author":"Fabian PGV","year":"2011","unstructured":"Fabian PGV, Alexandre G, Vincent M, et al: Scikit-learn: Machine learning in python. J Mach Learn Res 12:2825-2830, 2011","journal-title":"J Mach Learn Res"},{"key":"e_1_3_7_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-05318-5"},{"key":"e_1_3_7_18_2","first-page":"6639","volume-title":"CatBoost: Unbiased boosting with categorical features, in Advances in Neural Information Processing Systems 31 (NeurIPS 2018). Red Hook, NY","author":"Prokhorenkova L","year":"2018","unstructured":"Prokhorenkova L, Gusev G, Vorobev A, et al: CatBoost: Unbiased boosting with categorical features, in Advances in Neural Information Processing Systems 31 (NeurIPS 2018). Red Hook, NY, Curran Associates, 2018, pp 6639-6649"},{"key":"e_1_3_7_19_2","first-page":"1015","volume-title":"Beyond Accuracy, F-score and ROC: A Family of Discriminant Measures for Performance Evaluation","author":"Sokolova MJN","year":"2006","unstructured":"Sokolova MJN, Szpakowicz S: Beyond Accuracy, F-score and ROC: A Family of Discriminant Measures for Performance Evaluation. Berlin Heidelberg, Springer, 2006, pp 1015-1021"},{"key":"e_1_3_7_20_2","volume-title":"Part of Advances in Neural Information Processing Systems 30 (NIPS 2017)","author":"Lundberg SM","year":"2017","unstructured":"Lundberg SM, Lee S-I: A unified approach to interpreting model predictions. Part of Advances in Neural Information Processing Systems 30 (NIPS 2017), 2017"},{"key":"e_1_3_7_21_2","first-page":"1","article-title":"Scikit-survival: A library for time-to-event analysis built on top of scikit-learn","volume":"21","author":"P\u00f6lsterl S","year":"2020","unstructured":"P\u00f6lsterl S: Scikit-survival: A library for time-to-event analysis built on top of scikit-learn. J Mach Learn Res 21:1-6, 2020","journal-title":"J Mach Learn Res"},{"key":"e_1_3_7_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.16199"},{"key":"e_1_3_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.08.1590"},{"key":"e_1_3_7_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2018.01.078"},{"key":"e_1_3_7_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-019-1288-7"},{"key":"e_1_3_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188409"},{"key":"e_1_3_7_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33236"},{"key":"e_1_3_7_28_2","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6186543"},{"key":"e_1_3_7_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-022-00346-5"},{"key":"e_1_3_7_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.06.010"},{"key":"e_1_3_7_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31207"},{"key":"e_1_3_7_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyaf007"}],"container-title":["JCO Clinical Cancer Informatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/CCI-25-00124","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T21:00:16Z","timestamp":1764709216000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/CCI-25-00124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1200\/CCI-25-00124"],"URL":"https:\/\/doi.org\/10.1200\/cci-25-00124","relation":{},"ISSN":["2473-4276"],"issn-type":[{"value":"2473-4276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"2025-04-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-01","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2500124"}}